Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
115.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.40 (1.203%)
Market Cap: £206.21m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

New Reporting Structure

26 Jun 2024 14:00

RNS Number : 0095U
TT Electronics PLC
26 June 2024
 

 

26 June 2024

 

TT Electronics plc

 

New Reporting Structure

 

 

TT Electronics plc ("TT", "the Group"), a global engineer and manufacturer of electronic solutions for critical applications, today publishes historical financial information for 2023, including the half year splits, reflecting the new, three region structure.

 

As part of the Capital Market Event on 9 April we articulated the move to a function-led, regional reporting structure. This move from our previous divisional structure will enable us to better leverage our strong engineering and manufacturing capabilities to improve execution, unlock value and improve returns. 

 

The regional reporting structure will be used with effect from the forthcoming interim 2024 results, to be announced on 8 August. For purposes of transparency, supplementary disclosure covering the previous divisional segment performance will be provided at both the interim 2024 results and for the full year 2024 results in early March 2025. There will be no further divisional disclosure beyond this point.

 

The historical financial information contained in the following tables is unaudited.

 

 

Revenue £m

H1 2023

H2 2023

FY 2023

Europe

81.5

88.1

169.6

North America

115.4

114.1

229.5

Asia

112.2

102.6

214.8

Group revenue

309.1

304.8

613.9

 

 

 

Operating profit £m

H1 2023

H2 2023

FY 2023

Europe

4.3

7.6

11.9

North America

13.1

12.0

25.1

Asia

12.1

11.8

23.9

Central costs

(3.9)

(4.2)

(8.1)

Operating profit

25.6

27.2

52.8

 

 

Regional performance in FY23

 

Within the 2023 performance Project Albert accounted for £51.4 million of revenue in Europe and £17.2 million in Asia. By regional operating profit, the three business units disposed accounted for £0.2 million in Europe and £1.7 million in Asia respectively.

 

Pass through revenue is all within the Asia region and was circa £12.6 million in H1 and circa £19.9 million in the full year 2023.

 

 

EUROPE

 

H1 2023

H2 2023

FY 2023

Revenue

81.5

88.1

169.6

Adjusted operating profit1

4.3

7.6

11.9

Adjusted operating margin1

5.3%

8.6%

7.0%

 

NORTH AMERICA

 

H1 2023

H2 2023

FY 2023

Revenue

115.4

114.1

229.5

Adjusted operating profit1

13.1

12.0

25.1

Adjusted operating margin1

11.4%

10.5%

10.9%

 

ASIA

 

H1 2023

H2 2023

FY 2023

Revenue

112.2

102.6

214.8

Adjusted operating profit1

12.1

11.8

23.9

Adjusted operating margin1

10.8%

11.5%

11.1%

 

 

2023 END MARKET EXPOSURE

%

Europe

North America

Asia

Healthcare

3.8

16.7

47.2

Aerospace & Defence

41.6

21.1

2.1

Automation & Electrification

33.3

26.4

48.6

Distribution channel

21.3

35.8

2.1

Total

100

100

100

 

 

 

 

 

 

 

For further information please contact:

 

 

TT Electronics plc

Tel: +44 (0)1932 827 779

Peter France, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Kate Moy, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Ollie Hoare

 

 

 

 

Notes:

 

1. Definitions of Adjusted operating profit and Adjusted operating margin can be found on page 174 of our 2023 Annual Report and Accounts

2. TT will announce its half year results on 8 August 2024.

3. Latest company compiled view of market expectations shows a consensus adjusted profit before tax of £46.2 million within a range of £45.0 million to £47.3 million for the year ended December 2024.

 

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers primarily in the healthcare, aerospace & defence and automation & electrification sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities in the UK, North America and Asia.

Cautionary statement

This update contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNVURSUUNUAR
Date   Source Headline
1st Sep 202311:00 amRNSDirector Declaration
1st Sep 202310:58 amRNSTotal Voting Rights
25th Aug 20238:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNSHalf-year Results
27th Jul 20237:00 amRNSCEO Appointment
27th Jun 20235:35 pmRNSHolding(s) in Company
15th Jun 20232:32 pmRNSHolding(s) in Company
13th Jun 20234:11 pmRNSHolding(s) in Company
1st Jun 20235:06 pmRNSTotal Voting Rights
10th May 20233:12 pmRNSBoard Committee Change
10th May 202311:14 amRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 202311:12 amRNSBlock listing six monthly return
24th Apr 20233:18 pmRNSHolding(s) in Company
17th Apr 20239:21 amRNSHolding(s) in Company
13th Apr 20237:00 amRNSBoard Change
6th Apr 20234:33 pmRNSHolding(s) in Company
6th Apr 20237:46 amRNSHolding(s) in Company
5th Apr 20235:46 pmRNSDirector/PDMR Shareholding
5th Apr 20233:48 pmRNSAnnual Financial Report
31st Mar 20231:25 pmRNSHolding(s) in Company
28th Mar 20233:59 pmRNSDirector/PDMR Shareholding
20th Mar 202311:28 amRNSLong Term Incentive Plan
20th Mar 202311:25 amRNSDeferred Share Bonus Plan
17th Mar 20231:09 pmRNSDirector/PDMR Shareholding
15th Mar 202312:12 pmRNSDirector/PDMR Shareholding
13th Mar 20232:24 pmRNSHolding(s) in Company
10th Mar 20233:47 pmRNSHolding(s) in Company
8th Mar 20237:00 amRNSFull Year Results
1st Mar 20235:08 pmRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFY 22 Post Close Trading Update
1st Feb 20234:27 pmRNSTotal Voting Rights
9th Jan 20237:00 amRNSNED Appointments
1st Dec 20225:04 pmRNSTotal Voting Rights
21st Nov 20227:00 amRNSUpdate on U.K. DB Pension Scheme
10th Nov 20227:00 amRNSTrading Update
1st Nov 20221:59 pmRNSBlock Listing Six Monthly Return
5th Oct 20224:41 pmRNSSecond Price Monitoring Extn
5th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Sep 202212:59 pmRNSDirector Declaration
1st Sep 202212:49 pmRNSTotal Voting Rights
4th Aug 20227:00 amRNSHalf-year Results
1st Aug 20223:10 pmRNSTotal Voting Rights
11th Jul 20222:00 pmRNSHolding(s) in Company
1st Jul 20224:30 pmRNSTotal Voting Rights
1st Jun 20221:00 pmRNSTotal Voting Rights
13th May 202212:00 pmRNSResult of AGM
13th May 20227:00 amRNSAGM Trading Update
3rd May 20223:15 pmRNSBlock listing Interim Review
3rd May 20223:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.